← SynDRA
HESPERADIN
SynDRA canonical compound SYN0018686 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | AURKB |
| Mechanism of action | Aurora kinase inhibitor |
All known targets
Mechanisms of action (all sources)
- AURKB INHIBITOR
- aurora kinase inhibitor
Cross-references
Synonyms
- hesperadine
- UNII-PTR491OS14
- CHEBI:70726
- TCMDC-135395
- CHEMBL514409
- PTR491OS14
- (Z)-N-(2-oxo-3-(phenyl((4-(piperidin-1-ylmethyl)phenyl)amino)methylene)indolin-5-yl)ethanesulfonamide
- N-[(3Z)-2-oxo-3-[phenyl-[4-(piperidin-1-ylmethyl)anilino]methylidene]-1H-indol-5-yl]ethanesulfonamide
- Ethanesulfonamide, N-(2,3-dihydro-2-oxo-3-((3Z)-phenyl((4-(1-piperidinylmethyl)phenyl)amino)methylene)-1H-indol-5-yl)-
- N-[(3Z)-2-oxo-3-(phenyl{[4-(piperidin-1-ylmethyl)phenyl]amino}methylidene)-2,3-dihydro-1H-indol-5-yl]ethanesulfonamide
- N-{(3Z)-2-oxo-3-[phenyl({4-[(piperidin-1-yl)methyl]phenyl}amino)methylidene]-2,3-dihydro-1H-indol-5-yl}ethanesulfonamide
- FE7
- MLS006011039
- N-[2,3-Dihydro-2-oxo-3-[(3Z)-phenyl[[4-(1-piperidinylmethyl)phenyl]amino]methylene]-1H-indol-5-yl]ethanesulfonamide
- GTPL8354
- SCHEMBL1116351
- SCHEMBL1116356
- DTXSID00195086
- BDBM192753
- HMS3654N20
- BCP02222
- EX-A2067
- ZINC3944221
- MFCD18074526
- s1529
- AKOS030243077
- ZINC115270495
- CCG-269827
- CS-0213
- SB19304
- NCGC00346542-01
- NCGC00346542-10
- (Z)-N-(2-oxo-3-(phenyl(4-(piperidin-1-ylmethyl)phenylamino)methylene)indolin-5-yl)ethanesulfonamide
- AC-35920
- AS-35163
- DA-33583
- HY-12054
- N-[2-hydroxy-3-[C-phenyl-N-[4-(piperidin-1-ylmethyl)phenyl]carbonimidoyl]-1H-indol-5-yl]ethanesulfonamide
Look up HESPERADIN in the interactive SynDRA portal →